ALTO Reauthorization Act of 2021

Bill 117 HR 4846, also known as the ALTO Reauthorization Act of 2021, is a piece of legislation currently being considered by the US Congress. The bill aims to reauthorize the Alternatives to Opioids (ALTO) in the Emergency Department Program, which was originally established in 2018 to provide funding for hospitals to implement alternative pain management strategies in emergency departments.

The ALTO program focuses on reducing the use of opioids for pain management by promoting the use of non-opioid alternatives, such as nerve blocks, acupuncture, and physical therapy. The program has been successful in helping to reduce opioid prescriptions and overdose deaths in emergency departments across the country.

If passed, the ALTO Reauthorization Act of 2021 would provide continued funding for the ALTO program, allowing more hospitals to implement these alternative pain management strategies. The bill also includes provisions for monitoring and evaluating the effectiveness of the program, as well as reporting requirements to ensure transparency and accountability. Overall, the ALTO Reauthorization Act of 2021 aims to build on the success of the ALTO program and further reduce the reliance on opioids for pain management in emergency departments. It is an important piece of legislation in the ongoing efforts to combat the opioid epidemic in the United States.